Exagen Announces Publication of Systematic Review Confirming Robust Real-World Performance of AVISE LupusGlobeNewsWire • 06/01/26
How Much Upside is Left in Exagen (XGN)? Wall Street Analysts Think 73.05%Zacks Investment Research • 05/28/26
Exagen Inc. to Announce Fourth Quarter and Full Year 2025 Financial Results on March 10, 2026GlobeNewsWire • 02/24/26